Two doctors have been found guilty of falsely certifying Medicare patients were terminally ill and qualified for hospice care. However, the vast majority of the patients actually were not dying.
Two doctors have been found guilty of falsely certifying Medicare patients were terminally ill and qualified for hospice care. However, the vast majority of the patients actually were not dying.
Sri Wijegoonaratna, MD, and Boyao Huang, MD, participated in a scheme related to California Hospice Care (CHC), which submitted $8.8 million in fraudulent bills for hospice-related services between March 2009 and June 2013, according to the Department of Justice US Attorney’s Office in the Central District of California.
“A number of patients admitted to California Hospice Care testified at trial, showing that they did not require end-of-life care,” United States Attorney Eileen M. Decker, said in a statement. “In fact, only a small percentage of patients later died — notwithstanding the two doctors declaring that they needed hospice care.”
Dr Wijegoonaratna was found guilty on 7 counts of healthcare fraud, while Dr Huang was found guilty of 4 counts. They are scheduled to be sentenced on August 15 and face a maximum sentence of 10 years in federal prison for each count. There were 4 other defendants named in a federal grand jury indictment in September 2014. They pled guilty and their sentences are pending.
As part of the scheme, Priscilla Villabroza, who operated CHC, and her daughter paid patient recruiters to bring in Medicare and Medi-Cal beneficiaries. Drs Wijegoonaratna and Huang would then certify the beneficiaries were terminally ill and CHC would alter medical records to make the beneficiaries appear sicker.
“This scheme is one of many that has victimized public health care programs and, in the end, the taxpayers who fund these important programs. We will continue to investigate these fraudulent schemes, shut down the operations and incarcerate those responsible for stealing from the system,” Decker said.
Dr Wijegoonaratna also recruited patients into the fraud scheme and received tens of thousands of dollars in illegal kickbacks. The scheme was eventually shut down in June 2013, but Medicare and Medi-Cal had paid nearly $7.4 million to CHC for medically unnecessary hospice-related services, according to the attorney’s office.
Prices for care at hospital trauma centers vary across hospitals; drug shortages reached a record high during the first quarter of 2024; although 3 of the biggest makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35, these do not apply to daily inhalers used by the youngest kids with asthma.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
The Biden administration recently launched the Global Health Security Strategy, a new effort to combat the spread of infectious diseases; lawmakers zeroed in on the risks of massive consolidation in health care during the first congressional hearing on the Change Healthcare hack; the FDA recently announced the recall of a pair of heart devices linked to numerous deaths and injuries.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Prices for care at hospital trauma centers vary across hospitals; drug shortages reached a record high during the first quarter of 2024; although 3 of the biggest makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35, these do not apply to daily inhalers used by the youngest kids with asthma.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
The Biden administration recently launched the Global Health Security Strategy, a new effort to combat the spread of infectious diseases; lawmakers zeroed in on the risks of massive consolidation in health care during the first congressional hearing on the Change Healthcare hack; the FDA recently announced the recall of a pair of heart devices linked to numerous deaths and injuries.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
2 Commerce Drive
Cranbury, NJ 08512